- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Cinthya Pena Orbea Discusses Socioeconomic Impacts on Sleep-Disordered Breathing
Many socioeconomic factors, such as neighborhood factors, access to care, and education can influence sleep, explained Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic.
At SLEEP 2022, Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic, discussed how socioeconomic factors can influence sleep-disordered breathing.
What did your study find about the relationship between socioeconomic status and sleep-disordered breathing?
There are many socioeconomic factors that can influence sleep, and that could be neighborhood factors, access to care, education. In our study, what we wanted to study is the association between ADI—which stands for area deprivation index, which is a biomarker of neighborhood socioeconomic disadvantage—the association of these and sleep disorder breathing measures. What we found was that sleep-related hypoxia was higher among those people living in higher areas of deprivation.
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
